RemSleep Holdings (RMSL) Capital Expenditures Growth (3y) (2018 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | RemSleep Holdings | - | - | -7,636.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 20.97% |
| Dec 31, 2023 | 272.96% |
| Sep 30, 2023 | -4.01% |
| Mar 31, 2023 | 157.77% |
| Dec 31, 2022 | 6.09% |
| Jun 30, 2022 | 167.33% |
| Mar 31, 2022 | 0.56% |
| Dec 31, 2021 | 19.31% |
| Sep 30, 2021 | 3.00% |
| Dec 31, 2018 | 2,469.52% |